Abstract
Scutellaria barbata D. Don (SB) is a well known formula in traditional Chinese medicine, which exhibits potent anticancer effects on various cancers. Many miRNAs play crucial roles in the regulation of cancer, for instance, miR‑34a functions as a tumor suppressor, and is often downregulated during cancer. In this study, we investigated the role of ECSB in suppressing the growth of human colon cancer HCT‑8 cells, and whether this is mediated by regulation of miR‑34a and its downstream target genes, using real-time PCR and western blot analysis. ECSB treatment significantly inhibited the proliferation of HCT‑8 cells and promoted apoptosis in a dose-dependent manner. In addition, ECSB treatment significantly increased the level of miR‑34a expression and decreased the levels of Bcl-2, Notch1/2 and Jagged1 expression. Furthermore, knockdown of miR‑34a expression through transfection of anti-miR‑34a oligonucleotide was significantly reversed by ECSB treatment. Likewise, knockdown of miR‑34a resulted in significant upregulation of Bcl-2, Notch1/2 and Jagged1 expression, which was reversed following ECSB treatment. Therefore, this study reveals that ECSB inhibited cancer cell growth via promoting apoptosis and inhibiting proliferation,...Continue Reading
References
Jan 28, 2004·Cell·David P Bartel
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Jun 2, 2007·Molecular Cell·Nina Raver-ShapiraMoshe Oren
Apr 30, 2008·Phytotherapy Research : PTR·Kyung-Woon KimCheorl-Ho Kim
Aug 23, 2008·Cell Cycle·Dmitri LodyginHeiko Hermeking
May 23, 2009·Cell Death and Differentiation·H Hermeking
Sep 24, 2009·Cancer Research·Yunqing LiRoger Abounader
Mar 31, 2010·Carcinogenesis·Ronald T K PangWilliam S B Yeung
Dec 27, 2011·Carcinogenesis·Jianmin WuKai-Fu Tang
Feb 22, 2012·Journal of Ethnopharmacology·Alessandro BurianiPeter J Hylands
Sep 6, 2012·International Journal of Molecular Sciences·Lihui WeiJun Peng
Nov 7, 2012·Journal of Cellular Biochemistry·Feng GaoHuijun Duan
Nov 13, 2012·Current Drug Targets·Jun XiaZhiwei Wang
Jan 29, 2013·Oncology Reports·Lihui WeiJun Peng
May 7, 2013·Cell Stem Cell·Pengcheng BuXiling Shen
Aug 31, 2013·PloS One·Yiming MaHongying Wang
Nov 14, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jie GaoWang-Gang Zhang
Nov 16, 2013·Integrative Cancer Therapies·Jiumao LinJun Peng
Dec 18, 2013·Molecular Medicine Reports·Ling ZhangJun Peng
Mar 19, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 26, 2014·Oncology Letters·Changcun ZhangJie Fan
Nov 26, 2014·International Journal of Oncology·Aling ShenJun Peng
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jul 3, 2015·Oncology Letters·Junfeng YangY I He
Dec 2, 2015·Experimental and Therapeutic Medicine·Qiqin JiangJun Peng
Dec 2, 2015·Oncotarget·Lina CekaiteRagnhild A Lothe
Nov 1, 2014·Thoracic Cancer·Huajiao GuoJian Zhang
Mar 12, 2016·Journal of Experimental & Clinical Cancer Research : CR·Yudan Chi, Dongming Zhou
Mar 19, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Li-Tao PanZhi-Ming Cai
Apr 20, 2016·Biochimica Et Biophysica Acta·Hui JiaFan Feng
May 14, 2016·Journal of the Royal Society, Interface·Marcelo BoaretoJose' N Onuchic
Citations
Aug 18, 2018·Food & Function·Yueliang ZhaoMingfu Wang
Mar 20, 2018·Oncotarget·Yueqiang JiangJianHai Sun
Sep 2, 2020·Phytotherapy Research : PTR·Grace Gar-Lee YueClara Bik-San Lau
Aug 28, 2019·Oncology Letters·Ling ZhangJiu-Mao Lin
Aug 8, 2020·Journal of Integrative Medicine·Mu-Yan KongJin-Jun Wu
Jun 10, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Wenjun Li, Hongxia Xiao
Sep 25, 2021·The Journal of Pharmacy and Pharmacology·Zi-Bo LiuChun-Jie Wu
Jul 20, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Samira EghbaliFerizZahra Tayarani-Najaran